Heartflow FFRCT Analysis Sustains 44% Reduction In Unnecessary Invasive Angiography At One Year, FUSION Trial Confirms
Share
Why It Matters
HeartFlow's heart-scanning technology helped doctors avoid unnecessary procedures in almost half their patients. When a company's product keeps working well over time, it shows the tool is trusted and might help the business grow.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.